Loading...
Price History
Market Data
| Market Cap | - |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | 0.62 |
| Current Ratio | 1.50 |
| Currency | USD |
Key Financial Metrics
98.28M
Revenue
3.73M
Net Income
-
EPS (Diluted)
9.20M
Free Cash Flow
Profitability
Gross Margin
50.5%
Operating Margin
6.6%
Net Profit Margin
3.8%
EBITDA
15.39M
Returns & Efficiency
Return on Assets (ROA)
3.7%
Return on Equity (ROE)
6.0%
Dividend Yield
-
EPS
-
Financial Health
Total Assets
101.01M
Total Debt
-
Debt to Equity
0.62x
Current Ratio
1.50
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| HQ | NEWTOWN, PA |
| Fiscal Year | 2012 |
Peers
14.31B
P/E: 42.6
14.31B
P/E: 42.6
NEOGENOMICS INC
NEO
933.35M
P/E: --
SPHERIX INC
DOMH
46.72M
P/E: 0.4
3.76M
P/E: 0.0
BNB PLUS CORP.
BNBX
3.76M
P/E: 0.0
DIGIPATH, INC.
FUNI
3.25M
P/E: --
HYPHA LABS, INC.
FUNI
3.25M
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap-
P/E Ratio (TTM)-
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin50.5%
Operating Margin6.6%
Net Margin3.8%
ROE6.0%
ROA3.7%
Leverage & Liquidity
Debt to Equity0.62
Current Ratio1.50
Total Debt-
Total Assets$101.01M
Stockholders' Equity$62.46M
Income Statement (FY 2012)
Revenue$98.28M
Gross Profit$49.64M
Operating Income$6.51M
Net Income$3.73M
EPS (Diluted)-
Cash Flow (FY 2012)
Free Cash Flow$9.20M
Cash & Equivalents$13.91M
Revenue Growth17.0%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 826 NEWTOWN-YARDLEY ROAD NEWTOWN, PA 18940-1721 |
| Phone | 2677573000 |
| Incorporated | DE, US |
| EIN | 112872047 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 15.66M |
| Stockholders' Equity | $62.46M |
| Cash & Equivalents | $13.91M |
Recent Filings
View All
15-12G
Deregistration (12g)
Certification of termination of registration under 12(g)
Filed: 2013-03-29
EFFECT
Effectiveness Notice
Notice of effectiveness
Filed: 2013-03-28
EFFECT
Effectiveness Notice
Notice of effectiveness
Filed: 2013-03-28
EFFECT
Effectiveness Notice
Notice of effectiveness
Filed: 2013-03-28
EFFECT
Effectiveness Notice
Notice of effectiveness
Filed: 2013-03-28
S-8 POS
Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS
Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS
Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS
Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS
Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS
Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS
Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS
Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
POS AM
Post-Effective Amendment
Post-effective amendment to registration statement
Filed: 2013-03-22
POS AM
Post-Effective Amendment
Post-effective amendment to registration statement
Filed: 2013-03-22
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | BIOCLINICA INC |
| Ticker | None |
| Exchange | -- |
| Sector | Services |
| Industry | -- |
| Headquarters | NEWTOWN, PA |
| Fiscal Year | 2012 |
Financial Summary
| Market Cap | - |
| Revenue | 98.28M |
| Net Income | 3.73M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | 3.8% |
| ROE | 6.0% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...